InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $0.685 0.01 (1.48%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Regulatory Application Filed for Australian Manufacturing 2 Nov 2026 8:36AM $0.680 $0.685 risen by 0.74%
$25 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 9:17AM $0.710 $0.685 fallen by 3.52%
$25 Annual Report (Typeset) 27 Oct 2026 2:59PM $0.735 $0.685 fallen by 6.80%
$25 Peer-Reviewed Study Reports 100% Disease Control 27 Oct 2026 8:57AM $0.700 $0.685 fallen by 2.14%
$25 Change of Director's Interest Notice 26 Oct 2026 3:27PM $0.700 $0.685 fallen by 2.14%
$25 Notification of cessation of securities - OSL 26 Oct 2026 3:24PM $0.700 $0.685 fallen by 2.14%
$25 Updated OSPREY Overall Survival Data Presented at EAMN 21 Oct 2026 9:10AM $0.815 $0.685 fallen by 15.95%
$25 Notice of Annual General Meeting/Proxy Form 19 Oct 2026 10:01AM $0.795 $0.685 fallen by 13.84%
$25 Application for quotation of securities - OSL 15 Oct 2026 3:34PM $0.675 $0.685 risen by 1.48%
$25 PALACROS Officially Launched in Amsterdam 13 Oct 2026 9:59AM $0.695 $0.685 fallen by 1.44%
$25 OncoSil Clinical Data to be Presented at EANM 2026 30 Sep 2026 9:27AM $0.850 $0.685 fallen by 19.41%
$25 Notice of AGM date 28 Sep 2026 1:26PM $0.825 $0.685 fallen by 16.97%
$25 Notice under ASX Listing Rule 3.10A 15 Sep 2026 9:04AM $0.980 $0.685 fallen by 30.10%
$25 Change in substantial holding 14 Sep 2026 4:52PM $0.980 $0.685 fallen by 30.10%
$25 Change in substantial shareholding from AEF 14 Sep 2026 8:39AM $0.975 $0.685 fallen by 29.74%
$25 Notice Under Section 708A 10 Sep 2026 11:21AM $1.040 $0.685 fallen by 34.13%
$25 Application for quotation of securities - OSL 10 Sep 2026 11:20AM $1.040 $0.685 fallen by 34.13%
$25 Application for quotation of securities - OSL 10 Sep 2026 11:16AM $1.040 $0.685 fallen by 34.13%
$25 Australian Manufacturing Facility Achieves ISO 13485 9 Sep 2026 8:43AM $1.065 $0.685 fallen by 35.68%
$25 100th Patient Treated with OncoSil device in Spain 8 Sep 2026 9:40AM $0.910 $0.685 fallen by 24.73%
$25 Proposed issue of securities - OSL 7 Sep 2026 5:12PM $0.910 $0.685 fallen by 24.73%
$25 OSL Secures $5.6 million from Major Institutional Investors 7 Sep 2026 5:11PM $0.910 $0.685 fallen by 24.73%
$25 OncoSil submits US Reimbursement Application (Updated) 2 Sep 2026 11:33AM $1.065 $0.685 fallen by 35.68%
$25 OncoSil submits US Reimbursement Application 2 Sep 2026 10:27AM $1.070 $0.685 fallen by 35.98%
$25 Appendix 4G and Corporate Governance Statement 28 Aug 2026 4:03PM $1.175 $0.685 fallen by 41.70%

1 - 25 of 822 results

Page 1 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.